The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. (2009)

First Author: Kelleher MT
Attributed to:  Optical Proteomic Technology for In-Situ Analysis of Protein Interaction Networks funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s11523-009-0116-y

PubMed Identifier: 19756916

Publication URI: http://europepmc.org/abstract/MED/19756916

Type: Journal Article/Review

Volume: 4

Parent Publication: Targeted oncology

Issue: 3

ISSN: 1776-2596